Disease Activity

Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
Jian Tian, Chao Cheng, Fangjie Zhang

Annals of the Rheumatic Diseases Jun 2019, annrheumdis-2019-215745; DOI: 10.1136/annrheumdis-2019-215745
SAT0330 VALUE OF DIAPHRAGMATIC ASSESSMENT IN RELATION TO PULMONARY FUNCTIONS AND DISEASE ACTIVITY IN AXIAL SPONDYLOARTHROPATHIES: PRELIMINARY REPORT
Seçilay Güneş, Aysun Genç, İsmihan Sunar, Sevgi Esra Özdemir, Derya Gökmen, Şebnem Ataman, Yesim Kurtais Aytür

Annals of the Rheumatic Diseases Jun 2019, 78 (Suppl 2) 1244; DOI: 10.1136/annrheumdis-2019-eular.6081
Differentiating disease activity from damage in systemic sclerosis: it’s still early days!
Siddharth Jain, Shefali Khanna Sharma

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215588; DOI: 10.1136/annrheumdis-2019-215588
Disease activity and organ damage: different sides of the same coin in systemic sclerosis
Mandana Nikpour

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215639; DOI: 10.1136/annrheumdis-2019-215639
Response to: ‘Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?’ by Liu et al
Yasuhiro Kato, JeongHoon Park, Hyota Takamatsu, Atsushi Kumanogoh

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215540; DOI: 10.1136/annrheumdis-2019-215540
Response to ‘Decision making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?’ by Deng et al
Luis Eduardo Coelho Andrade, Jan Damoiseaux, Edward K Chan

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215640; DOI: 10.1136/annrheumdis-2019-215640
Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?
Pier Luigi Meroni, Edward K Chan, Jan Damoiseaux, Luís Eduardo Coelho Andrade, Xavier Bossuyt, Karsten Conrad, Xavier Mariette, Joanna Sheldon, Johan Rönnelid, Marvin J Fritzler

Annals of the Rheumatic Diseases Jun 2019, 78 (6) e46; DOI: 10.1136/annrheumdis-2018-213440
Response to: ‘Time to personalise the treatment of anti-MDA-5 associated lung disease’ by Lake et al
Valérie Leclair, Ingrid E Lundberg, Anna Tjärnlund

Annals of the Rheumatic Diseases Jun 2019, 78 (6) e53; DOI: 10.1136/annrheumdis-2018-213519
Response to: ’Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?' by Meroni et al
David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

Annals of the Rheumatic Diseases Jun 2019, 78 (6) e47; DOI: 10.1136/annrheumdis-2018-213537
Unexpected link between mitochondrial DNA and T cell help in systemic lupus erythematosus
David S Pisetsky

Annals of the Rheumatic Diseases Jun 2019, 78 (6) e59; DOI: 10.1136/annrheumdis-2019-215597

Main menu

Disease Activity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Disease Activity

Pages